Biofrontera Inc. cotiza a 0.93 USD y tiene una capitalización bursátil de $14M. En los últimos 12 meses ha facturado $46M con un margen de flujo de caja libre del -32.0%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-0.41 | $0.50 | $-0.57 |
| Estimado | $-0.04 | $-0.05 | $0.10 | $-0.56 |
| Sorpresa | — | -720.0% | +400.0% | -1.8% |
| Métrica | BFRI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -27.2% | -38.6% | +11.4% |
| Net Margin | -25.3% | -33.6% | +8.3% |
| FCF Margin | -32.0% | -13.9% | -18.2% |
| ROE | -100.5% | -40.4% | -60.1% |
| ROA | -36.9% | -32.0% | -4.9% |
| Current Ratio | 1.52 | 2.84 | -1.32 |
| Debt / Equity | — | 0.28 | — |